Eden Research said its commercial partner, Eastman Chemical Company, had made its first sales of Cedroz following the recent receipt of 'emergency' authorisation by the Italian authorities. Cedroz, which was initially developed and patented by Eden, was an innovative and natural solution designed to combat plant parasitic nematodes, pests that were known to cause severe damage to crops globally in both open field and greenhouse horticulture, resulting in yield losses and increasing growers costs, the company said. Eden produced and supplied Cedroz to Eastman in March this year in anticipation of regulatory clearance in Italy during the course of the 2019 growing season. 'Eastman has seized upon this earlier-than-anticipated opportunity to launch Cedroz in order to fully develop the market for this important product, and Eden has been more than happy to support them in their efforts to move the product to commercial use as quickly as possible, said Eden Research. At 9:56am: (LON:EDEN) Eden Research plc share price was 0p at 10.9p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.